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The use of beneficial microorganisms, the so-called probiotics, to improve human health is gaining popularity. However, not all of
the probiotic strains trigger the same responses and they differ in their interaction with the host. In spite of the limited knowledge
on mechanisms of action some of the probiotic effects seem to be exerted through maintenance of the gastrointestinal barrier
function and modulation of the immune system. In the present work, we have addressed in vitro the response of the intestinal
epithelial cell line HT29 to the strain Bifidobacterium breve IPLA20004. In the array of 84 genes involved in inflammation tested,
the expression of 12 was modified by the bifidobacteria. The genes of chemokine CXCL6, the chemokine receptor CCR7, and,
specially, the complement component C3 were upregulated. Indeed, HT29 cells cocultivated with B. breve produced significantly
higher levels of protein C3a. The proteome of HT29 cells showed increased levels of cytokeratin-8 in the presence of B. breve.
Altogether, it seems that B. breve IPLA20004 could favor the recruitment of innate immune cells to the mucosa reinforcing, as well
as the physical barrier of the intestinal epithelium.
1. Introduction
Probiotics are livemicroorganismswhichwhen administered
in adequate amounts confer a health benefit on the host [1],
the genusBifidobacterium being among themost widely used.
These microorganisms are common members of the human
gut microbiota and they predominate in breast-fed infants
[2]. Several beneficial health effects have been attributed
to specific probiotic strains [3]. Although the knowledge
on probiotic mechanisms of action is still limited some of
these beneficial effects are exerted through their role in the
maintenance of the gastrointestinal barrier function and by
modulating the immune system [4, 5].
The interest in the immunomodulatory properties of
probiotic bacteria derives from the observations that intesti-
nal microbiota plays a critical role in the development and
regulation of the immune system [6]. It is known that
different probiotic bacteria present different effects upon the
immune system [7, 8], making necessary the characterization
of the effects of each specific potentially probiotic strain.
Some strains promote Th1 responses, characterized by the
production of IFN𝛾 and TNF𝛼, whereas other strains induce
anti-inflammatory cytokines generating a Th2 profile [7, 8].
To determine these properties, the direct effect of the inter-
action of probiotic bifidobacteria with immune cells, either
total peripheral bloodmononuclear cells (PBMCs) or isolated
immune cell types, is often studied. However, the potential
effect of the cross talk between bifidobacteria and epithelial
cells upon the immune system has received less attention.
The intestinal epithelium separates microorganisms from the
underlying immune cells. It consists of a layer of cells, mainly
enterocytes, and a mucus layer that coats the epithelium [9].
Moreover, different immune cells are localized in the gut
associated lymphoid tissue, which constitute the first contact
point between gut commensals and the immune system
[10]. Consequently, assessing the effect of the interaction
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of potentially probiotic Bifidobacterium strains with the gut
mucosa constitutes an important task for both probiotics
selection and understanding of their mechanisms of action.
This understanding would allow selection of specific strains
with the desired properties for a specific application.
Previous studies carried out on the breast-milk isolate
Bifidobacterium breve IPLA20004 [11] by our group indi-
cated the ability of this strain to induce Th1 polarization of
lymphocytes and to increase the physical resistance of the
intestinalmucosa [12, 13].These results suggest that this strain
may be of interest for increasing the intestinal barrier against
pathogens, firstly by strengthening the physical resistance of
the epithelial layer and secondly by modulating the immune
system towards a preactivated steady state. Moreover, some
effects of the strain on the expression of chemokines and
their receptors have been previously suggested [13]. To this
regard an effect on the production of chemokines by intestinal
epithelial cells may have a direct impact on the immune
system by affecting the recruitment of immune cells to the
mucosa.
For the above-mentioned reasons we decided to evaluate
the effect of B. breve IPLA20004 on the expression of genes
related to the inflammatory response and on the production
of cytokines, by the human intestinal epithelial cell lineHT29.
Moreover, the effect of the strain on HT29 cells was also
assessed by proteomic analyses.
2. Materials and Methods
2.1. Bacteria Culture Conditions. To evaluate the effects of
the B. breve IPLA20004 on HT29 cells, cultures were freshly
prepared by growing the microorganisms in MRS medium
(Difco, Becton, Dickinson and Company, Le Pont de Claix,
France) supplementedwith a 0.25%L-cysteine (SigmaChem-
ical Co., St. Louis,MO,USA) (MRSc) at 37∘Cunder anaerobic
conditions (10%H
2
, 10%CO
2
, and 80%N
2
) in a chamberMac
500 (DonWhitley Scientific, West Yorkshire, UK).
2.2. HT29 Cell Line Culture Conditions. The epithelial intesti-
nal cell line HT29 (ECACC number 91072201), derived
from human colon adenocarcinoma, was purchased from the
European Collection of Cell Cultures (Salisbury, UK). HT29
cell culture passages 146-147 were used for the experiments.
The cell line was maintained in McCoy’s medium supple-
mented with 3mM L-glutamine, 10% (v/v) heat-inactivated
bovine fetal serum, and a mixture of antibiotics to give a
final concentration of 50𝜇g/mL penicillin, 50𝜇g/mL strepto-
mycin, 50 𝜇g/mL gentamicin, and 1.25 𝜇g/mL amphotericin
B. All media and supplements were obtained from Sigma.
The incubations took place at 37∘C, 5% CO
2
in an SL
water-jacketed CO
2
incubator (SheldonMfg. Inc., Cornelius,
Oregon, USA). Culture media were changed every two days
and the cell line was trypsinized with 0.25% trypsin-EDTA
solution (Sigma) following standard procedures. For gene
expression experiments and protein profile determinations,
105 cells/mL were seeded in 24-well plates and incubated
to reach a confluent and differential state (reaching about
107HT29 cells/mL) after 13 ± 1 days.
2.3. Gene Expression Analysis. B. breve IPLA20004 was
grown overnight in MRSc, harvested by centrifugation,
washed twice with Dulbecco’s PBS buffer (Sigma), and
resuspended in McCoy’s medium without antibiotics. Five
hundred 𝜇L of a bacterial suspension containing 108 cfu/mL
(as determined by plate counting) in McCoy’s medium or
McCoy’s medium without bacteria (control) was added to
each well containing HT29 monolayers (bacteria/HT29 cell
ratio 10 : 1) previously washed twice with Dulbecco’s PBS to
remove the antibiotics. Plates were then incubated for 6 h at
37∘C, 5% CO
2
in a Heracell 240 incubator (Thermo Electron
LDD GmbH, Langenselbold, Germany). After incubation
the culture media were removed and stored at −80∘C, the
monolayers were resuspended in 500𝜇L of RNA Protect Cell
Reagent (Qiagen GmbH, Hilden, Germany), and the cells
were kept frozen at−80∘Cuntil RNA extraction. At least three
independent experiments were carried out.
RNA from HT29 cells was extracted by using the
RNeasy Plus Mini Kit (Qiagen) and QIAshredder homoge-
nizer columns (Qiagen) followingmanufacturer instructions.
Quality of RNA was monitored by gel electrophoresis and it
was quantified by using an Epoch apparatus (BioTek Instru-
ments, Inc., Winooski, VT, USA). For reverse-transcriptase
PCR analyses 1 𝜇g of RNA was reverse-transcribed to cDNA
by using the RT2 First Strand Kit (SABiosciences, Qiagen,
Frederick, MD, USA), and gene expression was quantified
by using the 96-well RT2 Profiler PCR Array for human
inflammatory cytokines and receptors (SABiosciences) fol-
lowing manufacturer’s instructions. The array comprises 84
key genes involved in the inflammatory response includ-
ing chemokine and cytokine genes (CCL1 [I-309], CCL11
[eotaxin], CCL13 [mcp-4], CCL15 [MIP-1d], CCL16 [HCC-
4], CCL17 [TARC], CCL18 [PARC], CCL19, CCL2 [mcp-1],
CCL20 [MIP-3a], CCL21 [MIP-2], CCL23 [MPIF-1], CCL24
[MPIF-2/eotaxin-2], CCL25 [TECK], CCL26, CCL3 [MIP-
1a], CCL4 [MIP-1b], CCL5 [RANTES], CCL7 [mcp-3], CCL8
[mcp-2], CXCL1, CXCL10 [IP-10], CXCL11 [I-TAC/IP-9],
CXCL12 [SDF1], CXCL13, CXCL14, CXCL2, CXCL3, CXCL5
[ENA-78/LIX], CXCL6 [GCP-2], CXCL9, IL13, IL8, IFNA2,
IL10, IL13, IL17C, IL1A, IL1B, IL1F10, IL1F5, IL1F6, IL1F7,
IL1F8, IL1F9, IL22, IL5, IL8, IL9, LTA, LTB,MIF, SCYE1, SPP1,
and TNF), chemokine and cytokine receptor genes (CCR1,
CCR2, CCR3, CCR4, CCR5, CCR6, CCR7, CCR8, CCR9,
CX3CR1, XCR1 [CCXCR1], IL1R1, IL1RN, IL5RA, IL8RA,
IL8RB, IL9R, IL10RA, IL10RB, and IL13RA1), other genes
involved in the inflammatory response (ABCF1, BCL6, C3,
C4A, C5, CEBPB, CRP, ICEBERG, LTB4R, andTOLLIP), and
five housekeeping genes (B2M, HPRT1, RPL13A, GAPDH,
and ACTB) for normalization of data.
2.4. Cytokines and C3a Determination. Cytokine and C3a
levels in the cell culture supernatants of HT29 cells cultured
with or without B. breve as indicated above were quantified
by using the High Sensitivity ELISA Kits for human IL10,
IL12p70, IL1𝛽, and TNF𝛼 and the Platinum ELISA Kits for
human IL8 and C3a (eBioscience Inc., San Diego, CA, USA).
Colour development after ELISAwasmeasured in aModulus
Microplate Photometer (Turner Biosystems, Sunnyvale, CA,
USA). All the results were expressed as pg/mL. Detection
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limits for the ELISA kits used were 0.05, 0.1, 0.05, 0.13, 2,
and 70 pg/mL for IL10, IL12p70, IL1𝛽, TNF𝛼, IL8, and C3a,
respectively.
2.5. Determination of the Proteomic Profiles. B. breve
IPLA20004 was grown and added to the wells containing
HT29 as previously indicated. Plates were then incubated
for 3 h at 37∘C, 5%CO
2
, gently washed three times with
Dulbecco’s PBS buffer to remove the nonadhered bacteria,
and the HT29 monolayers were kept for further proteomic
analysis.
For protein extraction and two-dimensional electropho-
resis analysis, HT29 monolayers were disaggregated with
440 𝜇L of lysis buffer (30mMTris, 7Murea, 2M thiourea, 4%
(w/v) CHAPS, and 100mMDTT; all reagents were purchased
by GE Healthcare Life Sciences) containing complete pro-
tease inhibitors (Roche Diagnostics, Mannheim, Germany).
Total protein from the cell suspensions was obtained by
sonication for one min in ice-chilled water (two cycles),
with one min of delay between the two cycles. After adding
2mg of RNase A (Sigma-Aldrich) and 100U of DNase I
(Sigma-Aldrich), the cell lysates were incubated for 30min at
RT. Finally, the pellet was centrifuged for 10min at 16,000 g
and 4∘C to precipitate insoluble components and cell debris.
Protein concentration was estimated using the BCA Protein
Assay Kit (Pierce, Rockford, IL).
Isoelectric focusing (IEF) was performed in immobilized
pH gradient (IPG) strips containing a nonlinear pH range of
3–10 (GE Healthcare Life Sciences), using 500𝜇g of protein.
When needed, lysis buffer was added up to 450𝜇L. In all the
cases, the IPG-buffer corresponding to pHs 3–10was added to
a final concentration of 0.5% (v/v). IEFwas conducted at 20∘C
for 60,000 Vhrs in an IPGphor system (GE Healthcare Life
Sciences). Proteins were resolved by SDS-PAGE (12.5%w/v
polyacrylamide gel) and stained with GelCode Blue Safe Pro-
tein Stain (Pierce). Gels were scanned using ImageScanner
(GEHealthcare Life Sciences), and spot detection and volume
quantification were performed with ImageMaster Platinum
software (version 5.00, GE Healthcare). The relative volume
of each spot was obtained by determining the spot intensity
in pixel units and normalizing that value to the sum of the
intensities of all the spots of the gel. Each experiment was
performed independently four times, and the differences in
normalized volumes were analyzed statistically using paired
Student’s 𝑡-tests (control condition versus presence of the
bifidobacteria strain).
2.6. Statistical Analyses. Differences in the measured vari-
ables, between the control HT29 cells and those exposed to
the B. breve strain, were evaluated by one-way ANOVA test.
Results were represented by mean ± standard deviation. The
SPSS 18.0 statistical software package (SPSS Inc., Chicago, IL,
USA) was used for all determinations and a value of 𝑃 < 0.05
was considered significant.
3. Results
3.1. Effect of B. breve IPLA20004 on the Expression of Genes
Mediating the Inflammatory Response in HT29 Cells. When
Table 1: Changes in cytokines and receptors gene expression in
HT29 cells after exposition to bifidobacteria when compared to
exposition to culture medium without bifidobacteria (control), as
determined by RT-PCR.
Up- or downregulation (compared to control)
Gene B. breve IPLA20004
Fold regulation 𝑃
C3 17.71 0.001
CCL2 −3.29 0.026
CCL25 −5.32 0.039
CCR1 −2.60 0.012
CCR4 −6.07 0.006
CCR5 −10.36 0.004
CCR7 3.19 0.011
CXCL6 2.12 0.028
CXCL14 −2.43 0.015
IL10 −1.64 0.021
IL13 −2.75 0.009
XCR1 −3.65 0.001
using the human inflammatory cytokines and receptors
pathway focused RT-PCR array, comprising 84 key genes
involved in the inflammatory response, we observed some
statistically significant changes in gene expression in HT29
cells after coincubation with B. breve IPLA20004. These
changeswere in generalmodest andmost of the studied genes
were expressed at low basal levels (Ct values around 30, data
not shown), with the exception of CCL25 (Ct value of 19 in the
control HT29 cells) and CCR1 (Ct value 26 in the control).
The genes whose expression was significantly modified by
the strain are shown in Table 1. The expression of chemokine
genes CCL2, CCL25, and CXCL14 and the cytokines genes
IL10 and IL13 genes was significantly downregulated. On
the contrary the gene for CXCL6 chemokine was found to
be upregulated. With regard to chemokine receptor genes,
a statistically significant downregulation of CCR1, CCR4,
CCR5, and XCR1 and induction of CCR7 were observed.
Interestingly, B. breve IPLA20004 upregulated very signifi-
cantly (17-fold) the expression of the complement component
C3 (Table 1). No statistically significant differences were
observed for any of the other genes analyzed in the RT-PCR
array (data not shown).
3.2. Effect of B. breve IPLA20004 on Cytokines and C3 Pro-
duction by HT29 Cells. The levels of the different cytokines
measured, as well as those of C3a, in supernatants of HT29
cells are shown in Table 2. In general the levels detected
were low, in some cases being barely over the detection
limits of the ELISA kits used. No statistically significant
differences between control and B. breve-exposed HT29 cells
were observed for IL10, IL1𝛽, TNF𝛼, or IL8 levels. On the
contrary coculture of HT29 cells with B. breve IPLA20004
significantly increased the production of IL12p70 and C3a,
although for the former cytokine the detected levels (0.19 and
0.3 pg/mL for control and B. breve-exposed HT29 cells, resp.)
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Table 2: Effect of B. breve IPLA20004 on cytokines and C3a
levels in HT29 cells supernatants. All the results are expressed
as pg/mL. Control cells were exposed to culture medium without
bifidobacteria.
Concentration (pg/mL)
Control B. breve IPLA20004 𝑃
IL10 0.43 ± 0.44 0.83 ± 0.38 0.302
IL12p70 0.19 ± 0.03 0.30 ± 0.02 0.007
IL1𝛽 0.17 ± 0.17 0.26 ± 0.20 0.604
TNF𝛼 2.19 ± 1.45 3.35 ± 0.18 0.242
IL8 264.82 ± 38.41 423.51 ± 200.29 0.249
C3a 217.33 ± 38.37 311 ± 42.14 0.045
were only slightly above the detection limit of the technique
used and, therefore, the relevance of this observation is
unclear.
3.3. Effect of B. breve IPLA20004 on the Proteome of
HT29 Cells. The comparison of the proteomes of HT29
cells cocultured with or without B. breve revealed that
two proteins were significantly (𝑃 < 0.05) upregulated
in the HT29 cells by the strain B. breve IPLA20004 (see
Figure 1 in the Supplementary Material available online at
http://dx.doi.org/10.1155/2014/479140). These proteins were
excised from the gels and identified as cytokeratin-8 (2.8
times fold induction) and the chain A of the tapasin-ERp57
(4.7 times fold induction).
4. Discussion
The interaction of bacteria with intestinal epithelial cells
may play a role in immune modulation by modifying gene
expression and local immune environment through, for
instance, production of chemokines and other immune active
molecules. Chemokines are chemotactic cytokines that guide
the migration of cells regulating leukocyte traffic and exert
their effects by interacting with their specific receptors that
are selectively found on the surfaces of their target cells.
We studied the interaction of B. breve IPLA20004 with
colonic epithelial cells HT29 and found changes in the
expression of genes related to the inflammatory response
and immune cell chemotaxis in the HT29 cell line. The
strain was observed to significantly induce the expression
of some immunoactive molecules, such as C3 and CXCL6,
and to downregulate the expression of others including
CCL2, CCL25, CXCL14, IL10, or IL13. It should be noted,
however, that in some cases such as IL10 the magnitude of
the change in gene expression, although significant, was small
(less than 2) and perhaps of limited biological relevance.
The effect of probiotics, mainly Lactobacillus strains, on
transcriptional responses of human epithelial cells has been
previously assessed both in vitro [14–16] and in vivo [17–
19]. Although the studies on bifidobacteria are scarcer there
are also some examples [12, 13, 20, 21]. These studies show
a limited response of human intestinal epithelia cells lines
to stimulation with bifidobacteria. Nevertheless, it is still
interesting to see that our results, although in vitro, suggest
an effect of the strain B. breve IPLA20004 in a number of
genes coding for cytokines, chemokines, and receptors, which
is in agreement with some in vivo studies on the effect of
probiotic lactobacilli upon gene expression patterns in the
human small bowel [17] and supports a link between the
interaction of bacteria with epithelial cells and the immune
system. Interestingly, in spite of the different models used,
some of the genes found to be modulated in this study
have been previously reported to be modulated by probiotic
Lactobacillus strains both in vitro using epithelial cells [22]
and in vivo in the human small bowel mucosa [17, 19]. To
this regard, the colonic epithelial cell line used in our study
(HT29) may better resemble the small bowel, where the
mucus layer is thin, than the colon where a thick mucus
layer is known to be present which prevents the close contact
of bacteria with the epithelial cell [9]. Moreover, coculture
of mice primary colonic epithelial cells with L. rhamnosus
GG induced the expression of IL1𝛽, TNF𝛼, CXCL5 (ENA-
78), CXCL10 (IP10), CCL20 (MIP3𝛼), CCL2 (MCP1), CCL7
(MCP3), CXCL2 (MIP2𝛼), and CCL5 (RANTES) [22], and
our results indicated a significant downregulation of CCL2
without affecting the other L. rhamnosus GG-induced genes.
This may suggest a differential response to our bifidobacteria
with regard to L. rhamnosus GG, although the influence of
the different colonocyte models used cannot be overruled.
Administration of L. rhamnosus GG to human volunteers
induced the expression of some of these genes (CCL24,
CCL2, CXCL3, CXCL13, CXCL12, CCR3, CCL19, CCL21, or
lymphotoxin-𝛽 [LTB], among others) on the small bowel
mucosa, whilst other Lactobacillus strains (L. acidophilus
Lafti L10) resulted in a different expression profile (inducing
CXCL10 and CXCL11, among others) [19]. On the contrary,
generalizing, in our in vitro model B. breve IPLA20004
tended either to downregulate or not to affect these genes
which suggest a limited stimulatory activity of this strain
when compared with the immune-stimulatory ability of
lactobacilli. It should be noted, however, that the differences
existing between the in vivo studies and our in vitro results
with HT29 cells may be partly related to the different
experimental conditions used; for instance, we performed
the incubations under a 5% CO
2
atmosphere in comparison
with the anaerobic intestinal environmentwhichmay have an
effect on an anaerobic microorganism such as B. breve.
As indicated above, chemokines function mainly as
chemoattractants for leukocytes, recruiting monocytes, neu-
trophils, and other effectors cells from the blood to sites of
infection or tissue damage [23]. Chemokines such as CCL2
or CCL25 attract immune cells, such as macrophages and
T-lymphocytes expressing their receptors (CCR2 and CCR9,
resp.) to the tissue [23]. Actually, expression of CCR9 has
been found to be involved in the homing to the intestine of
thymic T-cells [24]. On the other hand, the only chemokine
gene found to be upregulated in our study was that of
CXCL6 (human granulocyte chemotactic protein-2, GCP-
2). This chemokine attracts and activates neutrophils [25]
being, together with IL8, the only CXC-family chemokine
recognized by both CXCR1 and CXCR2 receptors. IL8 is the
most active protein chemoattracting neutrophil, although in
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our study its gene was not found to be significantly upreg-
ulated and IL8 determination in the supernatants showed
higher, but not statistically significant, values. Moreover, a
recent study demonstrated an increased production of the
chemokine CXCL16 (not studied in this work) in germ-
free animals, which resulted in an increased recruitment of
immune cells to the intestinal mucosa [26]. This underlines
the importance of chemokines in immune cells recruitment
and the modulation of their production by the intestinal
microbiota.
Interestingly, the complement component C3 was among
the most strongly upregulated genes in the small bowel
mucosa after administration of L. rhamnosus GG to healthy
volunteers [17]. Similarly, the expression of this gene in HT29
cells was the most clearly upregulated by our B. breve strain
and a significantly higher production of C3 by the epithelial
cell line was confirmed by means of ELISA tests. C3 is the
most abundant complement protein in serum, it enhances
phagocytosis promoting innate immunity, and it is also
important for an effective antibody response, thus constitut-
ing a link between the complement system and the acquired
immune response [27]. In our study the downregulation of
the expression of genes such as CCL2 or CCL25 together
with the upregulation of the expression of CXCL6 and C3
by colonic cells suggests a local effect by suppressing the
recruitment to the mucosa of lymphocytes and by increasing
that of the innate immunity cells such as neutrophils and
mastocytes. However, the limitations of our study design do
not allow the establishment of firm conclusions on whether
the differences obtained with regard to the reports by other
authors are due to the different strains used or to the models’
responsiveness.
Finally, in order to complement the data on the inter-
action between B. breve IPLA20004 and HT29 cells we
performed a proteomic approach. This analysis allowed us
to detect the overproduction of cytokeratin-8 (CK-8) or type
I cytoskeletal 8, a keratin protein encoded by the krt8 gene;
this protein is located in the nucleoplasm and the cytoplasm
where, as a part of the cytoskeleton, it is known to help to link
the contractile machinery to dystrophin at the costamere in
striated muscle cells [28]. Interestingly, this strain has been
previously found to increase the transepithelial resistance
of the HT29 cell monolayer [13] which may be correlated
with this induction of changes in the cytoskeleton. Moreover,
the chain A of the tapasin-ERp57 was also overproduced.
The heterodimer formed by tapasin-ERp57, linked by a
stable disulfide bond, is part of the major histocompatibility
complex (MHC) class I peptide-loading complex [29]. This
heterodimer has been shown as the functional unit for load-
ing MHC class I molecules with high-affinity peptides [30].
It has been shown that upregulation of tapasin may facilitate
optimal peptide loading on the MHC class I molecule [31],
although the putative functions in enterocytes have passed
unnoticed until now.
In this study we have determined the effects of B.
breve IPLA20004 on intestinal epithelial cells, observing a
potential improvement of the epithelial barrier.This, together
with previous studies carried out on the interaction of the
strain with immune cells indicating a Th1 profile [8, 12] or
showing an increase of the transepithelial resistance of the
colonic epithelial cells monolayer [13], suggests the interest
in conducting experiments in which both polarized epithelial
cells and immune cells are cocultured.
In summary, our results suggest that this strain offers
possibilities for increasing the intestinal barrier against
pathogens in populations in which the barrier may be
compromised. This could be achieved by two independent
mechanisms: firstly by strengthening the cell cytoskeleton
and, therefore, the physical resistance of the epithelial layer
and secondly by modulating the immune environment at
local mucosal level towards a “prestimulated” innate immune
response by recruiting immune cells.
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